MedPath

Studies on type 2 diabetes in India

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/03/050658
Lead Sponsor
Asian Healthcare Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion criteria for T2DM cases are as follows: (1) Self-reported diabetes or medical record/report listing T2DM as a condition.

(2) Treatment naïve (i.e., no self-reported use of diabetes medication) to reduce confounding effects of drugs on the biomarkers,

(3) Individuals with high risk of developing diabetes and with family history of diabetes will be enrolled.

In parallel, we will recruit age, ethnicity and gender-matched healthy volunteers without T2DM as controls.

Exclusion Criteria

Patients who have diabetes related-complications or other co-morbidities will be excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Generation of islet transcriptome and proteome datasets from Indian individuals with T2DM <br/ ><br>2. Identification of functional, cellular, and/or molecular characters in Indian pancreata for biomarkers. <br/ ><br>3. Development of critical mass trained in translational research of islet biology and T2DM in India. <br/ ><br>4. Development of an interdisciplinary research team in collaboration with national and international institutes to study endocrine pancreasTimepoint: outcome 1 - 3 years <br/ ><br>outcome 2 - 3 years <br/ ><br>outcome 3 - 5 years <br/ ><br>outcome 4 - 1 year
Secondary Outcome Measures
NameTimeMethod
Identification of molecular pathways of type 2 diabetes in IndiaTimepoint: 4 years
© Copyright 2025. All Rights Reserved by MedPath